Lately, my virtual inbox in our electronic medical record has seen a surge in requests for prescriptions for the vaccine against Herpes Zoster, shingles. This has made me think a lot about our responsibility as physicians to inform patients about the evidence behind our recommendations – but who informs the patients when doctors are kept out of the loop or put under pressure to prescribe without seeing the patient?
What has happened is that our local Rite-Aid Pharmacy started to give these shots, covered by many insurers, but still requiring a doctor’s prescription.
I cannot give the shots in my clinic, because as a Federally Qualified Health Center, we are reimbursed at a fixed rate. The shingles vaccine costs more for us to buy than we charge for an entire office visit. I used to have the discussion about the shot, and would give patients a prescription to take to the pharmacy if they wanted it.
The pharmacy can give the shot at a profit, because it is considered a medication, just like a bottle of Lipitor.
The new system creates a bit of a dilemma for me. I get a message through the pharmacy that the patient wants the shot, and I don’t have the opportunity to sit down and review the effectiveness, side effects and long-term efficacy according to the available evidence with the patient.
For example, the shingles vaccine only cuts the risk of getting shingles in half. This is about the same effectiveness as the flu vaccine, but far less than, say, the vaccine against smallpox, which has now been eradicated.
Most patients are very surprised to hear about the 50% efficacy when I catch up with them at some later date; so many health care interventions are portrayed as both completely effective and absolutely necessary.
I see my role as a primary care physician as a guide and resource for patients, who are bombarded with overly optimistic claims and recommendations by mass media, drug companies and retailers.
Continue reading “What the EMR Saw”
Filed Under: Physicians, Uncategorized
Tagged: Country Doctor, Interventions, Patients, Pharmacies, primary care, Reimbursement, Scope of Practice
Jul 3, 2013
In November 2008, the New England Journal of Medicine convened a small roundtable to discuss “Redesigning Primary Care.”
U.S. primary care is in crisis, the roundtable’s description reads. As a result … [the] ranks are thinning, with practicing physicians burning out and trainees shunning primary care fields.
Nearly five years out — and dozens of reforms and pilots later — the primary care system’s condition may still be acute. But policymakers, health care leaders and other innovators are more determined than ever: After decades where primary care’s problems were largely ignored, they’re not letting this crisis go to waste.
Ongoing Shortage Forcing Decisions
The NEJM roundtable summarized the primary care problem thusly: Too few primary care doctors are trying to care for too many patients, who have a rising number of chronic conditions, and receive relatively little compensation for their efforts.
Continue reading “The Radical Rethinking of Primary Care Starts Now”
Filed Under: OP-ED, Physicians, THCB
Tagged: ACOs, Dan Diamond, Insurers, NEJM, NEJM Roundtable, paramedics, PCMH, Pharmacies, primary care, primary care shortage, The Affordable Care Act
Mar 7, 2013
Two-hundred-and-fifty-nine organizations have been named Medicare accountable care organizations. Most were formed by hospitals. Some were launched by physician groups.
And three were created by a pharmacy chain.
Walgreens’ move into shared savings is many things: unusual, eye-catching, a sign of the times.
But it’s not surprising, observers say, as the pharmacy chain has been cultivating a broader strategy to ramp up its role in frontline care. And through a handful of new programs, Walgreens already has “demonstrated … the valuable role our pharmacists can play working with physicians to meet the triple aim” of improving patient outcomes and satisfaction while cutting health costs, spokesperson Jim Cohn told me.
“ACOs are the next step.”
Continue reading “Is Walgreens the Future? What a Big Pharmacy Chain’s Moves Tell Us About Obamacare”
Filed Under: THCB, The Business of Health Care
Tagged: ACOs, Dan Diamond, National Association of Chain Drug Stores, National Community Pharmacists Association, Obamacare, Pharmacies, Pharmacists, shared savings program, The Affordable Care Act, Walgreens, WellTransitions
Feb 6, 2013